the Company issued 500 shares of Series Q Perpetual Preferred Stock to Uptown in exchange for a $12,500,000 reduction in the outstanding balance of the December 2020 Royalty Interest
the Redemption Shares (as defined hereunder) that may, from time to time, be issued or become issuable to the Investors under the Preferred Stock Purchase Agreements
Additionally, Napo is establishing a second processing site, which will be operated by Indena S.p.A. ('Indena'), a Milan, Italy-based contract manufacturer dedicated to the identification, developmen…
Our future revenue stream will substantially come from one customer, Woodward, and will solely be dependent on that certain manufacturing and supply agreement, dated January 12, 2026, by and among Na…
s promise to transfer Mytesi to specialty pharmacies based on specified payment and shipping terms as outlined in the Exclusive Distribution Agreement entered into by the Company and Cardinal Health,…
Reciprocal relationship from CAH graph: Reciprocal relationship from JAGX graph: Reciprocal relationship from CAH graph: Reciprocal relationship from JAGX graph: s promise to transfer Mytesi to speci…
Jaguar Health, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
JAGX-DEBT
Debt stack $43.6M
90%
Market cache reports total debt of $43.6M.
JAGX-DEBT-10414
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
JAGX-DEBT-10413
Warrants outstanding: 9580
90%
xbrl warrant detail from xbrl 2025-12-31.
Jaguar Health, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Jaguar Health, Inc..
Jaguar Health, Inc. Ownership
Holder
Name
Confidence
Evidence
JAGX-OWNER-UBS-GROUP-AG
UBS Group AG
90%
13F overlay lists UBS Group AG as top holder; 12 tracked holders.